On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- Video: “Stay or Pay” Agreements, Developing Immigration News, EEOC Power Shift - Employment Law This Week
- New York’s Trapped at Work Act, in Effect for Now, but New Bill Aims to Amend Terms and Extend Effective Date
- Video: How Jonathan Brenner Delivers Creative Legal Solutions for California Employers
- Video: FMLA and FLSA Compliance in 2026—New DOL Opinion Letters and Emerging Risks - Employment Law This Week
- Federal Shutdowns and Workplace Law: Navigating Legal Uncertainty